Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in people aged over 16, as the US prepares to get its booster campaign underway.
Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 ...
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
In his resignation letter, Marks wrote that health secretary Robert F. Kennedy Jr. wanted "subservient confirmation of his ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results